GlassScriptPhysician profile
Waleed Al-Hardan
NPI 1134743511
$76,310.98
in general payments reported to CMS, 2019-2025
12 companies · $3,190 in 2025
The $3,190 reported for 2025 was more than what 77% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $62K · 2023: $4,942 · 2024: $5,701 · 2025: $3,190.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $7,003 · Food and Beverage: $6,828.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $7,003.39 |
| Food and Beverage | $6,828.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Linkbio Corp | $60,000.00 | 2022 | |
| Stryker Corporation | $7,933.56 | 2022-2025 | Mako, Triathlon, Gmrs |
| Zimmer Biomet Holdings, INC. | $3,910.44 | 2022-2025 | Arcos, Persona, Rosa |
| Smith+Nephew, INC. | $2,043.66 | 2023-2025 | Journey II, Real Intelligence, Redapt |
| Prodigy Surgical Distribution, INC. | $1,039.60 | 2025 | |
| Depuy Synthes Sales INC. | $855.91 | 2022-2023 | Attune, Reclaim |
| Arthrex, INC. | $168.09 | 2025 | |
| Medacta USA, INC. | $134.96 | 2023 | Gmk Efficiency |
| Medical Device Business Services, INC. | $94.81 | 2022 | |
| Biocomposites INC | $89.60 | 2024 | |
| Exactech, INC. | $27.70 | 2022 | |
| Bioventus LLC | $12.65 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Waleed Al-Hardan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.